Hamburg, now a scientist at Ted Turner’s Nuclear Threat Initiative, which focuses on reducing the danger of “loose nukes” and other weapons of mass destruction, has a wealth of public health experience. She’s received two degrees from Harvard and at 36 became New York City’s youngest health commissioner.
Medical experts will be able to simultaneously review results of CT scans, MRIs, EKGs and other medical tests using one of Big Blue’s secure servers, regardless of their whereabouts.
The “radiology theatre” will feature live streaming audio and video to enable discussion, entering case notes and adding information to a patient’s record.
The Food & Drug Administration gave the nod to a pair of Hologic‘s tests for human papillomavirus.
The high-risk test determines if patients need a colposcopy and screens women 30 years old and older for high-risk HPV. It’s the first HPV DNA test approved by the FDA in more than 10 years, the company said.
Following a less than two-year stint on the board of directors at Boston Scientific Corp., J. Raymond Elliot resigned his seat to start a new, as-yet unspecified venture.
The Natick medical device colossus said March 9 that Elliot would not stand for re-election at the company’s annual shareholders meeting.
Somebody should give those guys a raise.
In the same week that NxStage Medical Inc. announced that company executives will not receive bonuses or raises after last year’s dismal stock performance, company officials said sales for the Lawrence-based dialysis maker jumped 115 percent in 2008.
NxStage, which makes dialysis equipment to treat end-stage renal failure, posted fourth-quarter sales of $35.7 million, up 19 percent over $29.8 million during the same period last year.
That helped the company narrow its net loss to $9.6 million for the quarter ended Dec. 31, 2008, compared with a net loss of $17.3 million during the fourth quarter of 2007.
Caliper Life Sciences Inc. took a big fourth-quarter hit to its balance sheet, widening its losses by 91 percent for the three-month period ended Dec. 31, 2008.
The Hopkinton-based lab equipment maker posted a $45 million charge on impairment of goodwill during the quarter.
That pushed the Caliper’s quarterly net loss to $46 million, compared to $5.7 million during the same period in 2007 — nearly 33 percent of its $68 million net loss for the full year. That, in turn, represents a 60 percent hike over the $24 million net loss Caliper posted for fiscal 2007.
If you sell to doctors in Massachusetts, say goodbye to the promotional pen.
A state agency finalized the nation’s toughest rules governing gifts by medical device manufacturers and pharmaceutical firms to physicians.
The regulations, enacted as part of a healthcare reform measure passed last summer, contain sweeping limits and outright bans on gifts to physicians, including meals, tickets and even pens.
Executives at NxStage will forego raises and bonuses for 2008, after the company’s compensation committee voted March 5 to freeze wages for 2009 and hold off on any incentive bonuses for last year’s performance.
Here are the highlights:
Children’s Hospital Boston inked a deal with CompuCyte that will see the Westwood laser cytometry equipment maker provide devices and services to researchers affiliated with Harvard Medical School.
CompuCyte will provide its laser scanning cytometry instruments and technical support and quantitative imaging cytometry and analysis services to researchers at the Longwood medical campus in Brookline.
Out of the frying pan and into … the skillet?
That’s about the size of it for Boston Scientific Corp., which saw its bond rating raised from negative to stable by Moody’s Investors Service. It’s good news, but there’s still a ways to go.
Moody’s upgraded the Natick-based medical device giant’s U.S. public bond rating March 10 from “Ba2” to “Ba1” and its liquidity rating from “SGL-3” to “SGL-2”, while affirming its corporate credit rating at “Ba1.”
Looking to push the company’s stock a little higher, Bruker Corp. chairman and CEO Frank Laukien upped his stake in the Billerica-based laboratory equipment maker between March 5 and March 10, according to a regulatory filing.